Use of slow-release melatonin in treatment-resistant depression.
about
sameAs
Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent modelsEfficacy and tolerability of agomelatine in the treatment of depressionHormone treatment of depression.An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.The use of herbal medications and dietary supplements by people with mental illness.Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.The pattern of melatonin receptor expression in the brain may influence antidepressant treatmentMood disorders, circadian rhythms, melatonin and melatonin agonists.Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?Objective and subjective measures for sleep disordersOptimizing the Pharmacologic Treatment of Insomnia: Current Status and Future HorizonsNew approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.Melatonin and human mitochondrial diseasesComparing the Effect of Preoperative Administration of Melatonin and Passiflora incarnata on Postoperative Cognitive Disorders in Adult Patients Undergoing Elective Surgery.Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain.Epigenetic regulation of melatonin receptors in neuropsychiatric disorders.
P2860
Q33557520-1B1C90C5-0472-4061-8475-50B8EA3E1CEBQ33583450-181700FD-6B61-4623-8DFA-D7FB1BC8FD9CQ34177698-922FC02C-AD00-4A06-9012-794F59BFD184Q34220649-143C2E19-9519-47EE-8DC8-9057D8CF5226Q34247521-64074837-148B-4431-BE30-ABF00F0C2658Q34358480-A1C19146-E8BE-4DCD-9A61-78F8F37ADE09Q35945875-0CEA798B-1455-417E-86FD-13C6F5F28E05Q36748061-6035C760-939B-4F25-B6D8-AD9C2C939F6BQ36790172-7A8E5976-150D-42A0-836C-29F674643040Q36905479-51BD63CE-C916-49FF-A3A7-CF07EA10D931Q37149325-11C100D4-3968-4EDE-B911-E21865FBFB06Q37235719-C9A03D30-901C-4310-AE37-E3F85D5FB8A9Q37715251-D370A4D0-0639-44DC-9271-1104F5D9947DQ41369749-398B2DD7-D8F2-472F-BA12-2C67469201D8Q42423474-2FDAC14D-4C9C-4195-B91A-708C85B6D14CQ48088836-6D821E1E-62B7-40E9-8B52-B522AC72410B
P2860
Use of slow-release melatonin in treatment-resistant depression.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Use of slow-release melatonin in treatment-resistant depression
@nl
Use of slow-release melatonin in treatment-resistant depression.
@ast
Use of slow-release melatonin in treatment-resistant depression.
@en
type
label
Use of slow-release melatonin in treatment-resistant depression
@nl
Use of slow-release melatonin in treatment-resistant depression.
@ast
Use of slow-release melatonin in treatment-resistant depression.
@en
prefLabel
Use of slow-release melatonin in treatment-resistant depression
@nl
Use of slow-release melatonin in treatment-resistant depression.
@ast
Use of slow-release melatonin in treatment-resistant depression.
@en
P2093
P2860
P1476
Use of slow-release melatonin in treatment-resistant depression.
@en
P2093
P2860
P407
P577
2000-01-01T00:00:00Z